Phase II trial of oxaliplatin, pemetrexed, and bevacizumab in previously-treated advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Heist, R. S.
Fidias, P.
Huberman, M.
Temel, J.
Sequist, L.
Lynch, T. J.
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7700
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I/II study of pembrolizumab (P) with gemcitabine (G) in patients (Pts) with previously-treated advanced non-small cell lung cancer (NSCLC): Phase I safety results
    Sanborn, Rachel E.
    Duffy, Regan M.
    Fisher, Brenda K.
    Perlewitz, Kelly Shea
    Redmond, William L.
    Koguchi, Yoshinobu
    Fox, Bernard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Phase II pharmacodynamic trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy
    Felip, E
    Rojo, F
    Heller, A
    Foernzler, D
    Majo, J
    Klughammer, B
    Ramos, J
    Maacke, H
    Brennscheidt, U
    Baselga, J
    LUNG CANCER, 2005, 49 : S369 - S369
  • [43] A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Shipley, Dianna L.
    Ervin, Thomas J.
    Kohler, Peter C.
    Lubiner, Eric T.
    Peyton, James D.
    Waterhouse, David M.
    Burris, Howard A., III
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) : 196 - 202
  • [44] Efficacy and safety of sunitinib in previously treated, advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II trial.
    Socinski, M. A.
    Novello, S.
    Sanchez, J. M.
    Brahmer, J. A.
    Govindan, R.
    Belani, C. P.
    Atkins, J. N.
    Gillenwater, H. H.
    Palleres, C.
    Chao, R. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 364S - 364S
  • [45] Bevacizumab in combination with anticancer drugs for previously treated advanced non-small cell lung cancer
    Liu, Ke-jun
    Ding, Ling-yu
    Wu, Hai-ying
    TUMOR BIOLOGY, 2015, 36 (03) : 1323 - 1327
  • [46] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [47] Phase II Study of Biweekly Pemetrexed and Gemcitabine in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Barton, John H.
    Patton, Jeffrey F.
    Zubkus, John D.
    Simons, Lisa
    Griner, Paula
    Burris, Howard A., III
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : 841 - 845
  • [48] Bevacizumab plus Weekly Paclitaxel with or Without Carboplatin for Previously-treated Non-squamous Non-Small Cell Lung Cancer
    Hata, Akito
    Katakami, Nobuyuki
    Tanaka, Kosuke
    Takeshita, Jumpei
    Matsumoto, Takeshi
    Monden, Kazuya
    Nagata, Kazuma
    Masago, Katsuhiro
    Kaji, Reiko
    Fujita, Shiro
    Tachikawa, Ryo
    Otsuka, Kyoko
    Otsuka, Kojiro
    Tomii, Keisuke
    ANTICANCER RESEARCH, 2014, 34 (1A) : 275 - 281
  • [49] ECONOMIC EVALUATION OF PEMETREXED IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER IN JAPAN
    Kamae, I
    Nakahara, N.
    Moriwaki, K.
    Enatsu, S.
    Nambu, Y.
    VALUE IN HEALTH, 2010, 13 (07) : A513 - A513
  • [50] Randomized Phase II Study of Pemetrexed versus Gefitinib for Patients with Previously Treated Non-Small Cell Lung Cancer
    Hong, Junshik
    Kyung, Sun Young
    Lee, Sang Pyo
    Park, Jeong Woong
    Jung, Sung Hwan
    Sym, Sun Jin
    Park, Jinny
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S401 - S401
12345